• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA VITEK® MS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA VITEK® MS Back to Search Results
Model Number 410895
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer from (b)(6) reported to biomérieux a misidentification in association with the vitek® ms instrument.The customer reported the vitek® ms results for a sample were no identification and single choice to clostridium difficile.The sample was tested with the vitek® 2 which gave a result of leuconostoc mesen (94%).The expected identification was unknown, however, the customer stated they knew from direct culture plates that it was an enterococcus.The customer reported that an incorrect result was not reported to a physician and patient results and treatment were not impacted.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer from (b)(6) had reported to biomérieux a misidentification in association with the vitek® ms instrument.Vitek ms result: * spot e1 : no identification * spot e2 : single choice to clostridium difficile.Other identification method: * vitek 2 = leuconostoc mesen * vre chrom and vitek gp card = enterococcus.A biomérieux internal investigation was performed using the data submitted by the customer.The strain was not submitted for further evaluation.Investigation conclusion: => conclusion on the system: system was operational during the test.=> conclusion on the identification: regarding the customer data, the most probable identification is enterococcus (based on vre chrom and vitek gp card).However, as no feedback was received about the results obtained after retest with a good quality spot preparation, it is not possible to conclude on the vitek ms results and define the root cause of the misidentification issue.To confirm the identification, the reference molecular method is sequencing.=> suspected root cause of the issue: the analysis of ecal mzml files indicates that "all peaks number" are not so homogeneous, which could be linked to the quality of the sample preparation.So the spot preparation has to be optimized.However, as no feedback has been received about the results obtained after retest with a good quality spot preparation, it is not possible to define the root cause of misidentification issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® MS
Type of Device
VITEK® MS
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR  38390
MDR Report Key6987723
MDR Text Key91345013
Report Number3002769706-2017-00323
Device Sequence Number1
Product Code PEX
Combination Product (y/n)N
PMA/PMN Number
DEN130013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 01/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number410895
Other Device ID Number03573026359119
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/05/2017
Initial Date FDA Received10/30/2017
Supplement Dates Manufacturer Received01/04/2018
Supplement Dates FDA Received01/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-